Dr. Muhammad Arslan Baig, MD

Dr. Baig practices at Endoscopy Center at Redbird Sq - HOPD in Dallas, Texas.

Dr. Baig's NPI, 1497121305, was assigned on August 13, 2015. Dr. Baig graduated from King Edward Medical University in 2012. Dr. Baig holds Texas license U3469.

Dr. Baig's primary practice is Endoscopy Center at Redbird Sq - HOPD, at 3107 W Camp Wisdom Rd, Dallas, TX 75237.

Dr. Baig's primary practice is Endoscopy Center at Redbird Sq - HOPD in Dallas, Texas. Dr. Baig is also affiliated with Methodist Dallas Medical Center. The medical group on file is Methodist Medical Group. Dmand AI also links Dr. Baig to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baig practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Baig's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Baig is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Baig's licenses on file in 3 states: Texas, Illinois and New Jersey.

Dmand AI lists acid reflux, colonoscopy, irritable bowel syndrome (IBS), pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Baig treats.

CMS data shows 826 Medicare services from Dr. Baig across 17 procedure codes in 2024, for 350 Medicare patients. Medicare paid $74,345 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 350 Medicare patients who saw Dr. Baig in 2024. The largest group is 65 to 74, with 173 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baig's median patient age at 65, with 54% women.

In 2024, Dr. Baig wrote 513 Medicare Part D claims for 270 patients. 80% of them were for generic drugs. CMS names the drug for 409 of them, across 8 drugs with 11 or more claims each, at $109,752 in total drug cost. In 2023, CMS named 145 claims across 3 drugs.

Dr. Baig accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Baig as offering telehealth. CMS counts 231 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Baig, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Baig, published from 2018 to 2023. 2020 was the busiest year, with 4. The most frequent topics are Carcinoma, Hepatocellular and Liver Neoplasms. Dr. Baig has published most often in Cureus. Dr. Baig's most frequent co-authors are Srinivas Reddy Puli, MD, Sonu Dhillon, MD and Shilpa Arora.

CMS Open Payments shows 129 general payments to Dr. Baig from 18 drug and device companies from 2017 to 2025. Grants make up the largest share, 77% of the total. Boston Scientific Corporation paid the most, $27,946.

Dr. Baig graduated from King Edward Medical University in 2012.

Dr. Baig is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.